Detalhe da pesquisa
1.
Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
Ann Surg
; 275(3): 440-447, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647708
2.
Medical Devices in Obesity Treatment.
Curr Diab Rep
; 19(10): 90, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471810
3.
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
EBioMedicine
; 88: 104430, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634565
4.
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib.
J Crohns Colitis
; 2023 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941436
5.
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
EClinicalMedicine
; 64: 102249, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842172
6.
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113896
7.
Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner.
Nutrients
; 14(10)2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35631283
8.
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study.
Lancet Gastroenterol Hepatol
; 7(4): 342-352, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123676
9.
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Lancet Gastroenterol Hepatol
; 7(11): 1005-1015, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088954
10.
Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK.
Am J Gastroenterol
; 106(7): 1281-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21577243
11.
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids.
Clin Nutr
; 40(4): 2343-2354, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131909
12.
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233964
13.
Magnets for therapy in the GI tract: a systematic review.
Gastrointest Endosc
; 82(2): 237-45, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25936447
14.
Characterization of inflammatory bowel disease with urinary metabolic profiling.
Am J Gastroenterol
; 104(6): 1435-44, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19491857
15.
Effectiveness of different recruitment strategies in an RCT of a surgical device: experience from the Endobarrier trial.
BMJ Open
; 9(11): e032439, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727662
16.
The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss.
Gastroenterol Res Pract
; 2018: 7823182, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30147720
17.
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
Diabetes Care
; 46(4): e89-e91, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716004
18.
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
BMJ Open
; 7(11): e018598, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146657
19.
Adenocarcinoma in situ arising from the submucosal oesophageal mucous glands.
Eur J Gastroenterol Hepatol
; 15(9): 1047-9, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12923381
20.
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
Am J Gastroenterol
; 102(4): 803-13, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17324124